Testosterone does not directly cause hair loss, but it serves as the raw material for a hormone that does. An enzyme in the scalp converts testosterone into dihydrotestosterone (DHT), and DHT is the molecule that shrinks hair follicles in people who are genetically susceptible. The distinction matters because it explains why many men with high testosterone keep a full head of hair while some with average levels go bald early. The real story is about how your follicles respond to DHT, not how much testosterone is circulating in your blood.
How Testosterone Becomes a Problem for Hair
Testosterone circulates throughout the body and is essential for muscle mass, bone density, libido, and dozens of other functions. It becomes relevant to hair loss only after an enzyme called 5-alpha reductase converts it into DHT inside the hair follicle itself. The type 2 form of this enzyme plays the central role in that conversion at the follicle level.1Dermatology. Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia DHT binds to androgen receptors on cells in the dermal papilla, the tiny cluster of tissue at the base of each hair follicle that controls the growth cycle. Once bound, DHT triggers a cascade of signals that progressively shorten the growth phase of each hair cycle. Over time, the follicle produces thinner, shorter hairs until eventually it yields only a fine, nearly invisible vellus hair or stops producing visible hair altogether.
Animal studies have confirmed this in a fairly direct way. When researchers applied DHT to hair follicles in mice, it triggered early regression of the hair cycle, miniaturization of the follicles, reduced hair density, and visible changes in hair structure.2Biomedicine & Pharmacotherapy. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia One of the key molecular players downstream of DHT is a growth factor called TGF-beta 1. Androgen stimulation increases production of reactive oxygen species in dermal papilla cells, and those reactive oxygen species in turn drive up TGF-beta 1 secretion, which suppresses hair growth. When researchers used an antioxidant to scavenge those reactive oxygen species, TGF-beta 1 levels dropped.3PubMed Central. Induction of transforming growth factor-beta 1 by androgen is mediated by reactive oxygen species in hair follicle dermal papilla cells
Despite decades of research, scientists still do not fully understand every step in this process. A 2025 review noted that it remains unclear exactly how androgens induce the miniaturization pattern, since neither differences in androgen receptor variants nor changes in local or circulating androgen levels fully explain it. Whether the process is primarily driven by changes in the follicle’s connective tissue or by events in the epithelial stem cell compartment is still an open question.4PubMed. Frontiers in the physiology of male pattern androgenetic alopecia: beyond the androgen horizon
Why Genetics Matter More Than Testosterone Levels
If testosterone were the whole story, then every man with high testosterone would go bald and every man with low testosterone would keep his hair. That clearly is not what happens. The missing piece is genetic variation in the androgen receptor gene, which sits on the X chromosome and is inherited from your mother’s side. Variations in this gene determine how sensitive your follicles are to DHT.
One early study found that a specific genetic marker in the androgen receptor gene appeared in 98% of young bald men compared to about 77% of non-bald men. Shorter repeat sequences in two regions of the gene were also more common in the bald group.5PubMed. Polymorphism of the androgen receptor gene is associated with male pattern baldness A larger genetic analysis later confirmed that variation in the androgen receptor gene is the single biggest genetic factor in early-onset androgenetic alopecia, with a particular repeat sequence in the gene identified as a strong candidate for the functional effect.6PubMed Central. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia
What this means in practice is that two men can have identical testosterone and DHT levels in their blood, yet one goes bald and the other does not, because their follicles respond differently to the same amount of DHT. Hair loss is polygenic, meaning many genes contribute, but the androgen receptor gene stands out as the dominant player.
Blood Hormone Levels Can Be Misleading
A common assumption is that getting a blood test for testosterone or DHT will predict whether you are going to lose your hair. It will not, at least not reliably. Researchers have found that the relevant hormone differences show up locally in the scalp tissue rather than in blood. In one study, DHT levels in balding scalp tissue were significantly higher than in non-balding scalp tissue from the same men, while testosterone levels at those sites were not meaningfully different.7PubMed. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness
Similarly, when researchers measured DHT levels in hair samples rather than blood, they found that DHT concentrations and the testosterone-to-epitestosterone ratio were elevated in hair from the balding vertex of men with premature hair loss. But the same measurements from the non-balding back of the head showed no significant difference compared to men without hair loss.8Journal of Dermatological Science. Comparative studies on level of androgens in hair and plasma with premature male-pattern baldness The takeaway is that hair loss is driven by what is happening in the tissue of specific scalp regions, not by what a general blood panel shows. This is why a man whose blood work looks entirely normal can still experience significant hair loss.
The Androgen Paradox
One of the stranger facts about androgens and hair is that the same hormones that cause hair loss on your scalp are responsible for growing hair on your face, chest, and other body sites. Researchers call this the “androgen paradox.” Androgens stimulate beard growth but suppress hair growth in androgenetic alopecia.9PubMed. Androgen actions on the human hair follicle: perspectives
The reason comes down to site-specific differences in how dermal papilla cells respond to the same hormonal signal. Follicles on the chin and jaw have dermal papilla cells that release growth-promoting signals when exposed to androgens. Follicles on the top of the scalp, in genetically predisposed people, have dermal papilla cells that instead release growth-inhibiting signals like TGF-beta 1. Both follicle types contain androgen receptors, but the downstream response goes in opposite directions. This is why men experiencing significant baldness often simultaneously grow thicker beards.
Anabolic Steroids and Testosterone Replacement
If your follicles are genetically sensitive to DHT, flooding the system with extra testosterone through steroids or hormone replacement therapy gives the enzyme more raw material to convert, potentially accelerating hair loss. In female athletes, androgenic and anabolic steroid use can induce or accelerate female pattern hair loss.10PubMed. Alopecia in Female Athletes Using Androgenic and Anabolic Steroids: Pathophysiology and Management In men, unregulated testosterone administration can lead to scalp balding because scalp tissue expresses a high density of androgen receptors and 5-alpha reductase.11Korean Journal of Sports Medicine. The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
A narrative review on hair loss among male athletes using testosterone found that in one prospective cohort study of 100 men using anabolic-androgenic steroids, only 2% reported hair loss at the beginning of their cycle. By roughly three and a half months in, that figure had risen to 12%.12PubMed Central. Hair loss in athletic testosterone use in males: a narrative review Not everyone on exogenous testosterone will lose hair. The genetic susceptibility still matters. But if you carry the relevant androgen receptor variants and begin taking testosterone or anabolic steroids, you are pressing the accelerator on a process that might have taken decades to become visible.
Women, Androgens, and Hair Loss
Female pattern hair loss tends to present differently from male pattern baldness. Rather than a receding hairline or bald spot at the crown, women typically experience diffuse thinning across the top of the scalp while the frontal hairline is preserved. The role of androgens in female hair loss is much murkier than in men. Most women with the frontal-central pattern of thinning have normal circulating androgen levels and no other signs of androgen excess like excess body hair or irregular periods.13The Journal of Clinical Endocrinology & Metabolism. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee This same pattern of hair loss has even been documented in women with a complete absence of circulating androgens or who lack a functional androgen receptor, which strongly suggests other mechanisms are at play.
That said, there is a subset of women where androgens do appear to be a factor. The most common hormonal condition associated with female pattern hair loss is polycystic ovary syndrome, which involves elevated androgen levels along with other metabolic and reproductive effects.14PubMed Central. Female pattern hair loss For these women, addressing the underlying hormonal imbalance may help slow hair thinning. But for the majority of women experiencing pattern hair loss, the testosterone connection that dominates the conversation in men does not apply cleanly.
What Current Treatments Target
The two mainstay medications for androgenetic alopecia both work by intervening in the testosterone-to-DHT pathway or by stimulating hair growth independently. Finasteride blocks the type 2 form of 5-alpha reductase, while dutasteride blocks both type 1 and type 2. Dutasteride suppresses circulating DHT levels by about 98%, compared to about 71% for finasteride.15PubMed Central. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study Minoxidil, by contrast, does not affect hormones at all. It works by increasing blood flow to the follicle and extending the growth phase of the hair cycle.
Combining the two approaches tends to outperform either one alone. A systematic review and meta-analysis found that the combination of finasteride and minoxidil produced significantly better results than either medication used by itself, with more patients showing marked improvement and fewer showing no change or worsening.16PubMed. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis Even topical formulations of finasteride combined with minoxidil have shown promise. In one randomized trial, the combination of topical finasteride 0.25% with minoxidil 5% achieved an efficacy rate of about 87%, compared to about 69% for minoxidil alone.17Journal of Drugs in Dermatology. Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia A separate prospective trial found that only the combination group achieved statistically significant increases in hair density at both three and six months, with about 79% of participants reaching meaningful photographic improvement compared to just 8% on topical finasteride alone and 41% on minoxidil alone.18PubMed. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia
Side Effects of DHT-Blocking Drugs
Because DHT does important work elsewhere in the body, blocking its production comes with trade-offs that anyone considering treatment should understand. A large pharmacovigilance analysis of adverse events reported to the FDA over two decades found that the most common complaints with finasteride were erectile dysfunction and sexual dysfunction. Depression and anxiety were significant adverse events in both men and women. Most adverse events appeared within the first month of treatment, though a notable number persisted beyond one year.19PLOS ONE. Multidimensional assessment of adverse events of finasteride: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
Longer-term concerns have also been raised. One review argued that blocking 5-alpha reductase creates a tissue-specific form of androgen deficiency even when circulating testosterone is normal, and that this could contribute to metabolic problems including fatty liver disease, insulin resistance, and type 2 diabetes over time.20PubMed Central. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm Another review noted that while the sexual side effects receive the most attention, adverse effects on mood, cognitive function, and metabolism also warrant further study, particularly the question of why a subset of patients experiences persistent symptoms even after stopping the drug.21PubMed. Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know? These risks do not mean the drugs are unsuitable for everyone, but they do mean the decision should involve an informed conversation with a doctor rather than a casual online purchase.
When Hair Loss Is Not About Androgens at All
Not all hair thinning follows the androgen-driven pattern. After roughly age 60, a separate process called senescent alopecia can occur. The mechanisms behind this age-related thinning are distinct from androgenetic alopecia. Androgen levels naturally decline with age, and so does the activity of 5-alpha reductase. Because the hormonal driver is fading rather than intensifying, using finasteride in older adults whose thinning began late is unlikely to produce meaningful regrowth.22Maturitas. Age-related hair changes in men: Mechanisms and management of alopecia and graying Senescent alopecia tends to thin hair diffusely across the entire scalp rather than following the classic receding-temples-and-crown pattern, which can help distinguish it clinically.
Other non-androgenic causes of hair loss include thyroid disorders, iron deficiency, autoimmune conditions like alopecia areata, and chronic telogen effluvium, where a large number of hairs prematurely enter the shedding phase in response to physiological stress. Assuming that any hair loss must be testosterone-related can lead people down the wrong treatment path entirely.
Hair Loss and Metabolic Health
An intriguing line of research connects early-onset androgenetic alopecia with metabolic risk factors. Several case-control studies have found that young men who develop pattern baldness early are more likely to show signs of insulin resistance and metabolic syndrome than age-matched men without hair loss. One study found that insulin resistance was present in 18% of the hair-loss group compared to 4% of controls, and metabolic syndrome was present in 21% versus 9%.23PubMed Central. Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early-Onset Androgenetic Alopecia: A Case-Control Study Another study found a significant association between androgenetic alopecia and metabolic syndrome, with waist circumference identified as the strongest independent risk factor.24PubMed Central. Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case–control study
The direction of causation is not established. Shared hormonal and inflammatory pathways could underlie both conditions, or some common genetic susceptibility may link them. But the association has practical value: researchers have suggested that early hair loss in young men could serve as a visible prompt to screen for cardiovascular and metabolic risk factors. Lifestyle changes such as weight management, regular exercise, and a diet with a lower glycemic index have been recommended as potentially beneficial for both metabolic health and possibly the trajectory of hair loss.25PubMed Central. The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case–Control Study
Emerging Research Beyond Hormone Blocking
Because the current drug options all have limitations, researchers are looking for ways to protect or regenerate follicles without manipulating the androgen pathway. One promising area involves exosomes, tiny vesicles secreted by stem cells that carry signaling molecules to other cells. Researchers found that exosomes from human umbilical cord mesenchymal stem cells could counteract DHT-induced disruptions in the hair growth cycle. The exosomes carried specific microRNAs that activated a growth-promoting signaling pathway in dermal papilla cells, essentially overriding the suppressive signal from DHT without altering hormone levels themselves.26PubMed Central. Human umbilical cord mesenchymal stem cell-derived exosomes enhance follicular regeneration in androgenetic alopecia via activation of Wnt/β-catenin pathway
This kind of approach is still far from clinical use, but it reflects a broader shift in thinking about hair loss treatment. Rather than simply reducing the amount of DHT reaching the follicle, newer strategies aim to make the follicle more resilient to DHT’s effects or to stimulate growth through entirely non-hormonal pathways. If successful, these could eventually offer options for people who cannot tolerate or prefer to avoid the side effects of finasteride and dutasteride.
Baldness as a Signal of Social Maturity
From an evolutionary perspective, the persistence of male pattern baldness is a puzzle. If it conferred no advantage, you might expect selection pressure to have eliminated or reduced it over time. One hypothesis frames both facial hair and scalp baldness as signals of different life stages. Beardedness is associated with sexual maturation and may signal aggressive dominance, while pattern baldness is associated with a later stage and may signal social maturity, a non-threatening form of dominance linked to experience and nurturing qualities.27Ethology and Sociobiology. The evolutionary significance and social perception of male pattern baldness and facial hair Whether this hypothesis holds up or not, it offers a reminder that baldness as a trait is deeply embedded in human biology, not a modern disease or a simple malfunction. The genes that contribute to it have been passed along for a very long time, which suggests they are intertwined with traits that conferred some reproductive or social advantage.